Updates are available Correction dated 2025-02-05
Click to view Correction: https://doi.org/10.1007/s00221-025-06996-y
-
Authors
Jäger, Ralf https://orcid.org/0000-0002-7345-9635
Abou Sawan, Sidney
Orrú, Marco
Tinsley, Grant M.
Purpura, Martin
Wells, Shawn D.
Liao, Kylin
Godavarthi, Ashok
-
Funding
Funding for this research was provided by:
Ingenious Ingredients. L.P. (Ingenious Ingredients. L.P.)
- License Information
-
More Information
Article History
Received: 29 December 2023
Accepted: 30 October 2024
First Online: 2 December 2024
Change Date: 29 January 2025
Change Type: Update
Change Details: The original online version of this article was revised due to several errors induced in the original article. This has been corrected now.
Change Date: 5 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00221-025-06996-y
Declarations
:
: R.J., M.P., S.D.W. and K.L. are researchers and principals of Ingenious Ingredients, the sponsor of the study, and inventors of numerous patent applications for the use of paraxanthine but have been involved in data collection or analysis. R.J., M.P. and S.D.W. serve on the scientific advisory board and K.L. is the CEO of NNB Nutrition, the manufacturer of the paraxanthine used in this study. S.A. is an employee of Iovate Health Sciences, a distributor of paraxanthine, but has not been involved in data collection or analysis. A.G. is employed by Radiant Research Services Pvt. Ltd., and Radiant Research is a CRO who has received funding from Ingenious Ingredients to conduct this study. G.M.T. provides consulting services, including statistical analysis and dietary supplement formulation, through Tinsley Consulting LLC but has no conflicts of interest related to the use of paraxanthine. M.O. declares no competing interests.
